Stimulation of pancreatic islet neogenesis: A possible treatment for type 1 and type 2 diabetes

Current Opinion in Endocrinology and Diabetes

Volumn 11, Issue 3, 2004, Pages 125-140

  Vinik, Aaron ^a,b   Rosenberg, Lawrence ^a   Pittenger, Gary L ^a   Taylor Fishwick, David ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b Strelitz Diabetes Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

CELL DIFFERENTIATION; CELL REGENERATION; CELL TRANSPLANTATION; EMBRYO DEVELOPMENT; GENETIC SUSCEPTIBILITY; HUMAN; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULAR MECHANICS; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS; PANCREAS DUCT; PANCREAS ISLET CELL; PERINATAL PERIOD; PROTEIN ANALYSIS; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; STIMULATION;

EID: 33645226049     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.med.0000125482.65536.0a     Document Type: Review

References (162)

1. Rosenberg L, Vinik AI: Induction of endocrine cell differentiation: a new approach to management of diabetes. J Lab Clin Med 1989, 114:75-83.
2. Hellerstrom C, Swenne I, Andersson A: Islet cell replication and diabetes. In The Pathology of the Endocrine Pancreas in Diabetes. Edited by Lefebre PJ, Pipeleers DG. Berlin/Heidelberg: Springer-Verlag; 1988:141-170.
3. Kloppel G, Lohr M, Habich K, et al.: Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res 1985, 4:110-125.
4. Wilander E, Boquist L, Rerup C, et al.: Functional and morphological studies of islet beta-cell regeneration in endogenous and exogenous diabetes. Acta Pathol Microbiol Scand [A] 1970, 78:496.
5. Hardikar AA, Karandikar MS, Bhonde RR: Effect of partial pancreatectomy on diabetic status in BALB/c mice. J Endocrinol 1999, 162:189-195.
6. Hayek A, Beattie GM: Experimental transplantation of human fetal and adult pancreatic islets. J Clin Endocrinol Metab 1997, 82:2471-2475.
7. Edlund H: Developmental biology of the pancreas. Diabetes 2001, 50:S5-S9.
8. Sander M, German MS: The B cell transcription factors and the development of the pancreas. J Mol Med 1997, 75:327-340.
9. St-Onge L, Wehr R, Gruss P: Pancreas development and diabetes. Curr Opin Genet 1999, 9:295-300.
10. Kim SK, Hebrok M: Intercellular signals regulating pancreas development and function. Genes Dev 2001, 15:111-127.
11. Deutsch G, Jung J, Zheng M, et al.: A bipotential precursor population for pancreas and liver with in the embryonic endoderm. Development 2001, 128:871-881.
12. Ahlgren U, Jonsson J, Jonsson L, et al.: Beta-cell-specific inactivation of the mouse lpt1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev 2001, 12:1763-1768.
13. Edlund H: Transcribing pancreas. Diabetes 1998, 47:1817-1823.
14. Pictet RL, Putter WJ: Development of the embryonic endocrine pancreas. In Handbook of Physiology, Section 7: Endocrinology, Vol. 1. Edited by Steiner DF, Freinkel N. Washington, DC: American Physiological Society; 1972:25-66.
15. Rooman I, Heremans Y, Heimberg H, et al.: Modulation of rat pancreatic acinoductal transdifferentiation and expression of PDX-1 in vitro. Diabetologia 2000, 43:907-914.
16. Zulewski H, Abraham EJ, Gerlach MJ, et al.: Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 2001, 50:521-533.
17. Teitelman G: On the origin of pancreatic endocrine cells, proliferation and neoplastic transformation. Tumour Biol 1993, 14:167-173.
18. Vinik AI, Rafaeloff R, Pittenger G, et al.: Induction of pancreatic islet neogenesis-an approach towards a cure for diabetes. Horm Metab Res 1997, 29:278-293.
19. Jenssen J, Heller RS, Funder-Nielsen T, et al.: Independent development of pancreatic and B cells from neurogenin-3 expressing precursors. Diabetes 2000, 49:163-176.
20. Pittenger G, Rafeloff R, Yan B, et al.: INGAP and Reg peptides stimulate proliferation of pancreatic duct epithelial cells but not insulin-secreting HIT cells. Diabetes 1995, 44(suppl 1):210A.
21. Shih DQ, Screenan S, Munoz KN, et al.: Loss of HNF-1 alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes 2001, 50:2472-2480.
22. Grapin-Botton A, Melton DA: Endoderm development: from patterning to organogenesis. Trends Genet 2000, 16:124-130.
23. Peers B, Leonard J, Sharma S, et al.: Insulin expression in pancreatic islet cells relies on cooperative interactions between the helix loop helix factor E47 and the homeobox factor STF-1. Mol Endocrinol 1994, 8:1798-1806.
24. Peers B, Sharma S, Johnson T, et al.: The pancreatic islet factor STF-1 binds cooperatively with Pbx to a regulatory element in the somatostatin promoter: importance of the FPWMK motif and of the homeodomain. Mol Cell Biol 1995, 15:7091-7097.
25. Serup P, Petersen HV, Pedersen EE, et al.: The homeodomain protein IPF-1/STF-1 is expressed in a subset of islet cells and promotes rat insulin 1 gene expression dependent on an intact E1 helix-loop-helix factor binding site. Biochem J 1995, 310:997-1003.
26. Guz Y, Montminy MR, Stein R, et al.: Expression of murine STF-1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny. Development 1995, 121:11-18.
27. Wang R, Li J, Rosenberg L: Factors mediating the transdifferentiation of islets of Langerhans to duct epithelial-like structures. J Endocrinol 2001, 171:309-318.
28. Stoffers DA, Ferrer J, Clarke WL, et al.: Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet 1997, 17:138-139.
29. Stoffers DA, Zinkin NT, Stanojevic V, et al.: Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 1997, 15:106-110.
30. Thomas MK, Devon ON, Lee JH, et al.: Development of diabetes mellitus in aging transgenic mice following suppression of pancreatic homeoprotein IDX-1. J Clin Invest 2001, 108:319-329.
31. Rafaeloff R, Rosenberg L, Vinik AI: Expression of growth factors in a pancreatic islet regeneration model. Adv Exp Med Biol 1992, 321:133-140.
32. Sharma A, Zangen DH, Reitz P: The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes 1999, 48:507-513.
33. Song SY, Gannon M, Washington MK: Expansion of Pdx-1-expressing pancreatic epithelium and islet neogenesis in transgenic mice overexpressing transforming growth factor alpha. Gastroenterology 1999, 117:1416-1426.
34. Kritzik MR, Jones E, Chen Z: PDX-1 and Msx-2 expression in the regeneration and developing pancreas. J Endocrinol 1999, 163:523-530.
35. Vinik A, Pittenger G, Rafaeloff R, et al.: Factors controlling pancreatic islet neogenesis. Tumour Biol 1993, 14:184-200.
36. McCarthy BG, Hsieh ST, Stocks A, et al.: Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 1995, 45:1848-1855.
37. Vinik A, Erbas T, Park T, et al.: Dermal neurovascular dysfunction in type 2 diabetes. Diabetes Care 2001, 24:1468-1475.
38. Pittenger GL, Vinik AI, Rosenberg L: The partial isolation and characterization of ilotropin, a novel islet-specific growth factor. Adv Exp Med Biol 1992, 321:123-132.
39. Thompson RJ, Doran JF, Jackson P, et al.: PGP 9.5-a new marker for vertebrate neurons and neuroendocrine cells. Brain Res 1983, 278:224-228.
40. Vinik A, Pittenger G, Rafaeloff R, et al.: Factors controlling pancreatic islet neogenesis. Yale J Biol Med 1992, 65:471-491.
41. Offield MF, Jetton TL, Labosky PA, et al.: PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 1996, 122:983-995.
42. Ahlgren U, Pfaff SL, Jessell TM, et al.: Independent requirement for ISL1 in formation of pancreatic mesenchyme and islet cells. Nature 1997, 385:257-260.
43. Sosa-Pineda B, Chowdhury K, Torres M, et al.: The Pax4 gene is essential for differentiation of insulin-producing beta cells in the mammalian pancreas. Nature 1997, 386:399-402.
44. St-Onge L, Sosa-Pineda B, Chowdhury K, et al.: Pax6 is required for differentiation of glucagon-producing alpha-cells in mouse pancreas. Nature 1997, 387:406-409.
45. Sussel L, Kalamaras J, Hartigan-O'Connor DJ, et al.: Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells. Development 1998, 125:2213-2221.
46. Li H, Arber S, Jessell TM, et al.: Selective agenesis of the dorsal pancreas in mice lacking homeobox gene H1xb9. Nat Genet 1999, 23:67-70.
47. Gradwohl G, Dierich A, LeMeur M, et al.: Neurogenin 3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci U S A 2000, 97:1607-1611.
48. Lee JE, Hollenberg SM, Snider L, et al.: Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein. Science 1995, 238:836-844.
49. Naya FJ, Huang HP, Qiu Y, et al.: Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes Dev 1997, 11:2323-2334.
50. Miyata T, Maeda T, Lee JE: NeuroD is required for differentiation of the granule cells in the cerebellum and hippocampus. Genes Dev 1999, 13:1647-1652.
51. Huang HP, Chu K, Nemoz-Gaillard E, et al.: Neogenesis of beta-cells in adult BETA2/NeuroD-deficient mice. Mol Endocrinol: Mar 2002, 16:541-551. This article highlights the protective action of beta cell neogenesis in BETA2/NeuroD-deficient mice.
52. Yamamoto K, Miyagawa J, Waguri M, et al.: Recombinant human betacellulin promotes the neogenesis of beta-cells and ameliorates glucose intolerance in mice with diabetes induced by selective alloxan perfusion. Diabetes 2000, 49:2021-2027.
53. Hoem D, Dalen H, Andren-Sandberg A, et al.: Nonadhesive organ culture of human exocrine pancreatic cells with their stroma. Pancreas 2002, 25:71-77.
54. Taylor-Fishwick DA, Rittman S, Kendall H, et al.: Cloning genomic INGAP: a Reg-related family member with distinct transcriptional regulation sites. Biochim Biophys Acta 2003, 1638:83-89.
55. Petersen HV, Jorgensen MC, Anderson FG, et al.: Pax4 represses pancreatic glucagon gene expression. Mol Cell Biol Res Commun 2000, 3:249-254.
56. Heremans et al.: J Biol Chem 2002. The authors describe the conversion of adult human pancreatic duct cells into insulin-expressing cells after expression of neurogenin 3. Conversion is associated with expression of genes and proteins known to be essential for beta cell differentiation.
57. Kahn BB: Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance. Cell 1998, 92:593-596.
58. Taylor SI: Deconstructing type 2 diabetes. Cell 1999, 97:9-12.
59. Fajans S, Bell G, Polonsky K: Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001, 345:971-980.
60. Shin D, Stoffel M: Dissecting the transcriptional network of pancreatic islets during development and differentiation. Proc Natl Acad Sci U S A 2001, 98:14189-14191.
61. Ben-Shushan E, Marshak S, Shoshkes M, et al.: A pancreatic beta-cell-specific enhancer in the human PDX-1 gene is regulated by hepatocyte nuclear factor 3 beta (HNF-3beta), HNF-1alpha, and SPs transcription factors. J Biol Chem 2001, 276:17533-17540.
62. Slack JM: Developmental biology of the pancreas. Development 1995, 121:1569-1580.
63. Bouwens L, Pipeleers DG: Extra-insular beta cells associated with ductules are frequent in adult human pancreas. Diabetologia 1998, 41:629-633.
64. Edlund H: Pancreas: how to get there from the gut? Curr Opin Cell Biol 1999, 11:663-668.
65. Bonner-Weir S, Taneja M: In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci U S A 2000, 97:7999-8004.
66. Guz Y, Nasir I, Teitelman G: Regeneration of pancreatic B cells from intra-islet precursor cells in an experimental model of diabetes. Endocrinology 2001, 142:4956-4968.
67. Pang K, Mukonoweshuro CH, Wong GG: Beta cells arise from glucose transporter type 2 (GLUT-2)-expressing epithelial cells of the developing rat pancreas. Proc Natl Acad Sci U S A 1992, 91:9559-9563.
68. Ramiya V, Maraist M, Arfors K, et al.: Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic cells. Nat Med 2000, 6:278-282.
69. Herrera PL: Defining the cell lineages of the islets of Langerhans using transgenic mice. Int J Dev Biol 2002, 46:97-103. This is an excellent review of the development of the mouse endocrine pancreas. It considers the development and derivation of adult glucagon- and insulin-producing cells in addition to their relationship to pancreatic polypeptide-expressing cells.
70. Rafaeloff-Phil R, Schmitt E, Edlund H, et al.: Expression of INGAP during ontogeny of the pancreas. Diabetes 1998, 41:A58.
71. Guz Y, Torres A, Teitelman G: Detrimental effect of protracted hyperglycaemia on beta-cell neogenesis in a mouse murine model of diabetes. Diabetologia 2002, 45:1689-1696. Islets gradually lose their regenerative potential when they are exposed to high circulating glucose concentrations for an extended period of time.
72. Lumelsky N, Blondel O, Laeng P, et al.: Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001, 292:1389-1394.
73. Assady S, Maor GAM, Itskovitz-Eldor J, et al.: Insulin production by human embryonic stem cells. Diabetes 2001, 50:1691-1697.
74. Soria B: Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 2000, 49:157-162.
75. Beattie GM, Itkin-Ansari P, Cirulli V, et al.: Sustained proliferation of PDX-1+ cells derived from human islets. Diabetes 1999, 48:1013-1019.
76. Cheung AT: Glucose-dependent insulin release from genetically engineered K cells. Science 2000, 290:1959-1960.
77. Cornelius JG, Tchernev V, Kao KJ, et al.: In vitro generation of islets in long-term cultures of pluripotent stem cells from adult mouse pancreas. Horm Metab Res 1997, 29:271-277.
78. Bonner-Weir S, Taneja M, Weir G, et al.: In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci U S A 2000, 97:7999-8004.
79. Levine S, Pictet R, Rutter WJ: Control of cell proliferation and cytodifferentiation by a factor reacting with the cell surface. Nature New Biol 1992, 246:49-52.
80. Itkin-Ansari P, Demeterco C, Bossie S, et al.: PDX-1 and cell-cell contact act in synergy to promote delta-cell development in a human pancreatic endocrine precursor cell line. Mol Endocrinol 2000, 14:814-822.
81. Dufayet de La Tour D, Halvorsen T, Demeterco C, et al.: B-cell differentiation from a human pancreatic cell line in vitro and in vivo. Mol Endocrinol 2001, 15:476-483.
82. Bertelli E, Regoli M, Orazioli D, et al.: Association between islets of Langerhans and pancreatic ductal system in adult rat. Where endocrine and exocrine meet together? Diabetologia 2001, 44:575-584.
83. Vinik AI: The enterohormones. Current status and review. S Afr Med J 1974, 48:359-364.
84. Bendayan M: Anatomic basis of islet-acinar interaction in the pancreas. Regul Pept Lett 1990, 2:8.
85. Creutzfeldt W, Folsch UR, Stockmann F: Clinical implications of islet-acinar interactions. Regul Pept Lett 1990, 2:8.
86. Colon JM, Rouiller D, Boden G, et al.: Characterization of immunoreactive components of inulin and somatostatin in canine pancreatic juice. FEBS Lett 1979, 105:23-26.
87. Ertan A, Taminato T, Akdamar K: Immunoreactive somatostatin in human pancreatic secretion. J Clin Endocrinol Metab 1981, 52:589-591.
88. Sarfati P, Green GM, Brazeau P, et al.: Presence of somatostatin-like immunoreactivity in rat pancreatic juice: a physiological phenomenon. Can J Physiol Pharmacol 1986, 64:539-544.
89. Buts JPDKN, Marandi S: Expression of insulin receptors and of 60-kDa receptor substrate in rat mature and immature enterocytes. Am J Physiol 1997, 273:G217-G226.
90. Gingerich RL, Gilbert WR, Comens PG, et al.: Identification and characterization of insulin receptors in basolateral membranes of dog intestinal mucosa. Diabetes 1987, 36:1124-1129.
91. Pillion DJ, Ganapathy V, Leibach FH: Identification of insulin receptors on the mucosal surface colon epithelial cells. J Biol Chem 1985, 260:5244-5247.
92. Miyaura C, Chen L, Appel M, et al.: Expression of reg/PSP, a pancreatic exocrine gene: relationship to changes in islet beta-cell mass. Mol Endocrinol 1991, 5:226-234.
93. Ohno T, Ishii C, Kato N: Increased expression of regenerating (reg) gene protein in neonatal rat pancreas treated with streptozotocin. Endocr J 1995, 42:649-653.
94. Rafaeloff R, Barlow SW, Rosenberg L, et al.: Expression of Reg gene in the Syrian golden hamster pancreatic islet regeneration model. Diabetologia 1995, 38:906-913.
95. Zenilman ME, Chen J, Danesh B, et al.: Characteristics of rat pancreatic regenerating protein. Surgery 1998, 124:855-863.
96. Sanchez D, Baeza N, Blouin R, et al.: Overexpression of the reg gene in non-obese diabetic mouse pancreas during active diabetogenesis is restricted to exocrine tissue. J Histochem Cytochem 2000, 48:1401-1410.
97. Okamoto H: Molecular basis of experimental diabetes: degeneration, oncogenesis and regeneration of pancreatic beta-cells of islet of Langerhans. Bioassays 1985, 2:15-21.
98. Yonemura Y, Takashima T, Matsuda Y, et al.: Induction of islet beta-cell regeneration in partially pancreatectomized rats by poly (ADP-ribose) synthetase inhibitors. Int J Pancreatol 1988, 3:73-82.
99. Rafaeloff R, Pittenger GL, Barlow SW, et al.: Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters. J Clin Invest 1997, 99:2100-2109.
100. Sasahara K, Yamaoka T, Moritani M, et al.: Molecular cloning and tissue-specific expression of a new member of the regenerating protein family, islet neogenesis-associated protein-related protein. Biochim Biophys Acta 2000, 1500:142-146.
101. Rosenberg L, Vinik A: Growth factors and islet neogenesis. In Methods in Cell Transplantation. Austin, TX: R.G. Landes; 1995:563-586.
102. Bank S, Marks IN: Clinical and hormonal aspects of pancreatic diabetes. Am J Gastroenterol 1975, 64:13-22.
103. In vivo derivation of glucose competent endocrine cells form bone marrow without evidence of cell fusion. J Clin Invest. This article provides evidence of a bone marrow-derived pancreatic stem cell.
104. Kodama S, Kuhtreiber W, Fujimura S, et al.: Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 2003, 302:1223-1227. The authors identify that splenocytes have the ability to rapidly differentiate into islet and ductal epithelial cells within the pancreas. This article provides evidence of the existence of an islet stem cell within the spleen and for pancreas specific maturation factors.
105. McArthur JC, Stocks EA, Hauer P, et al.: Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol 1998, 55:1513-1520.
106. Vinik AI, Pittenger GL, Rafaeloff R, et al.: Determinants of pancreatic islet mass: a balance between neogenesis and senescence/apoptosis. Diabetes Rev 1996, 4:235-263.
107. Rosenberg L, Duguid WP, Vinik AI: Cell proliferation in the pancreas of the Syrian golden hamster. Dig Dis Sci 1987, 32:1185.
108. Bouwens L, Kloppel G: Islet cell neogenesis in the pancreas. Virchows Arch 1996, 427:553-560.
109. Bouwens L, Wang RN, De Blay E, et al.: Cytokeratins as markers of ductal cell differentiation and islet neogenesis in the neonatal rat pancreas. Diabetes 1994, 43:1279-1283.
110. Hellerstrom C: The life story of the pancreatic B cell. Diabetologia 1984 26:393-400.
111. Rosenberg L, Vinik AI: Induction of endocrine cell differentiation-a new approach to diabetes. Clin Res 1987, 35:899.
112. Rosenberg L: In vivo cell transformation: neogenesis of beta cells from pancreatic ductal cells. Cell Transplant 1995, 4:371-383.
113. Rutter WJ: The development of the endocrine and exocrine pancreas. Monogr Pathol 1980, 21:30-38.
114. Teitelman G, Lee J, Reis DJ: Differentiation of prospective mouse pancreatic islet cells during development in vitro and during regeneration. Dev Biol 1987, 120:425-433.
115. Le Douarin MN: On the origin of pancreatic endocrine cells. Cell 1998, 53:169-171.
116. Teitelman G: Cellular and molecular analysis of pancreatic islet cell lineage and differentiation. Recent Prog Horm Res 1991, 47:259-294.
117. Alpert S, Hanahan D, Teitelman G: Hybrid insulin genes reveal a developmental lineage for pancreatic endocrine cells and imply a relationship with neurons. Cell 1988, 53:295-308.
118. Otonkoski T, Beattie GM, Rubin JS, et al.: Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes 1994, 43:947-953.
119. Makino T, Usuda N, Rao S, et al.: Transdifferentiation of ductular cells into hepatocytes in regenerating hamster pancreas. Lab Invest 1990, 62:552-561.
120. Kanaka-Gantenbein C, Dicou E, Czernichow P, et al.: Presence of nerve growth factor and its receptors in an in vitro model of islet cell development: implication in normal islet morphogenesis. Endocrinology 1995, 136:3154-3162.
121. Dudek RW, Lawrence IE Jr, Hill RS, et al.: Induction of islet cytodifferentiation by fetal mesenchyme in adult pancreatic ductal epithelium. Diabetes 1991, 40:1041-1048.
122. Oberg C, Waltenberger J, Claesson L, et al.: Expression of protein tyrosine kinases in islet cells: possible role of the Flk-1 receptor for beta-cell maturation from duct cells. Growth Factors 1994, 10:115-126.
123. Sjoholm A, Hellerstrom C: TGF-beta stimulates insulin secretion and blocks mitogenic response of pancreatic beta-cells to glucose. Am J Physiol 1991, 260:C1046-C1051.
124. Sjoholm A: Glucose stimulates islet beta-cell mitogenesis through GTP-binding proteins and by protein kinase C-dependent mechanisms. Diabetes 1997, 46:1141-1147.
125. Miettinen PJ, Otonkoski T, Voutilainen R: Insulin-like growth factor-II and transforming growth factor-alpha in developing human fetal pancreatic islets. J Endocrinol 1993, 138:127-136.
126. Hui H, Wright C, Perfetti R: Glucagon-like peptide 1 induces differentiation of islet duodenal horfieobox-1-positive pancreatic ductal cells into insulin-secreting cells. Diabetes 2001, 50:785-796.
127. Ritzel R, Schulte M, Porksen N, et al.: Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance. Diabetes 2001, 50:776-784.
128. Unno M, Yonekura H, Nakagawara K, et al.: Structure, chromosomal localization, and expression of mouse reg genes, reg I and reg II. A novel type of reg gene, reg II, exists in the mouse genome. J Biol Chem 1993, 268:15974-15982.
129. Larsen J, Hylleberg B, Ng K, et al.: Glucagon-like peptide-1 infusion must be maintained for 24h/day to obtain acceptable glycemia in type 2 diabetic patients who are poorly controlled on sulphonylurea treatment. Diabetes Care 2001, 24:1416-1421.
130. Egan JM, Meneilly GS, Elahi D: Effects of 1-mo bolus subcutaneous administration of exendin-4 in type 2 diabetes. Am J Physiol Endocrinol Metab 2002, 284:E1072-E1079.
131. Meneilly GS, Greig N, Tildesley H, et al.: Effects of 3 months of continuous subcutaneous administration of glucagon-like peptide 1 in elderly patients with type 2 diabetes. Diabetes Care 2003, 26:2835-2841.
132. Rafaeloff R, Barlow SW, Vinik A: Induction of pancreatic islet regeneration modulates expression of cell cycle-regulated genes: potential markers for proliferation and differentiation. Diabetes 1997, 46:A169.
133. Pittenger GL, Rosenberg L, Vinik AI: Partial purification and characterization of ilotropin, a pancreatic islet specific growth factor. J Cell Biol 1991, 115:270A.
134. Rafaeloff R, Qin XF, Barlow SW, et al.: Identification of differentially expressed genes induced in pancreatic islet neogenesis. FEBS Lett 1996, 378:219-223.
135. Watada H, Kajimoto Y, Umayahara Y, et al.: The human glucokinase gene beta-cell type promoter: an essential role of insulin promoter factor 1-PDX-in its activation in HIT-T15 cells. Diabetes 1996, 45:1478-1488.
136. Lasserre C, Christa L, Simon MT, et al.: A novel gene (HIP) activated in human primary liver cancer. Cancer Res 1992, 52:5089-5095.
137. Terazono K, Yamamoto H, Takasawa S, et al.: A novel gene activated in regenerating islets. J Biol Chem 1988, 263:2111-2114.
138. Perfetti R, Raygada M, Wang Y, et al.: Regenerating (reg) and insulin genes are expressed in prepancreatic mouse embryos. J Mol Endocrinol 1996, 17:79-88.
139. Anastasi E, Ponte E, Gradini R, et al.: Expression of Reg and cytokeratin 20 during ductal cell differentiation and proliferation in a mouse model of autoimmune diabetes. Eur J Endocrinol 1999, 141:644-652.
140. Kobayashi S, Akiyama T, Nata K, et al.: Identification of a receptor for Reg (regenerating gene) protein, a pancreatic B-cell regeneration factor. J Biol Chem 2000, 275:10723-10726.
141. Rosenberg L, Duguid WP, Brown RA, et al.: Induction of nesidioblastosis will reverse diabetes in Syrian golden hamster. Diabetes 1988, 37:334-341.
142. Rosenberg L, Brown RA, Duguid WP: Induction of experimental nesidioblastosis: a study of islet differentiation and function. Surg Forum 1982, 33:227-230.
143. Zotto H, Massa L, Rafaeloff R, et al.: Possible relationship between changes in islet neogenesis and islet neogenesis-associated protein-positive cell mass induced by sucrose administration to normal hamsters. J Endocrinol 2000, 165:725-733.
144. Itoh T, Tsuzuki H, Katoh T, et al.: Isolation and characterization of human reg protein produced in Saccharomyces cerevisiae. FEBS Lett 1990, 272:85-88.
145. Watanabe T, Yonekura H, Terazono K, et al.: Complete nucleotide sequence of human reg gene and its expression in normal and tumoral tissues. The reg protein, pancreatic stone protein, and pancreatic thread protein are one and the same product of the gene. J Biol Chem 1990, 265:7432-7439.
146. Vinik A: Pancreatic islet cell regeneration and growth. Adv Exp Med Biol 1992, 321:1-5.
147. Kojima H, Fujimiya M, Matsumura K, et al.: NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat Med 2003, 9:596-603.
148. Rosenberg L, Duguid WP, Kahlenberg M, et al.: Paracrine/autocrine regulation of pancreatic islet cell proliferation and differentiation in the hamster. Studies using parabiosis. J Clin Invest 1992.
149. Rosenberg L, Duguid WP, Brown RA: Effect of experimental nesidioblastosis on streptozotocin-induced diabetes. Surg Forum 1983, 34:48-51.
150. Gagliardino J, Del Zotto H, Masa L, et al.: Sucrose administration to normal hamsters induces simultaneous changes in islet neogenesis and INGAP-positive cell mass. Diabetes 1999, 48:A442.
151. Gagliardino J, Zotto H, Massa L, et al.: Simultaneous Increases in B-cell and in INGAP-positive cell mass in offspring of sucrose-fed pregnant normal hamsters. Diabetes 2000, 49:A415.
152. Jamal M, Lipsett M, Hazrati A, et al.: INGAP peptide induces in vitro islet cell neogenesis from human duct-like islet progenitor cells, program and sbstract. Endocrine Society, OR 30-2, 2002; 105.
153. Shapiro AM, Lakey JR, Ryan EA, et al.: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000, 343:230-238.
154. Lee H, Kim S, Kim K, et al.: Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue. Nature 2000, 408:483-488.
155. Weir GC, Bonner-Weir S, Leahy JL: Adverse effects of hyperglycemia upon the islets of Langerhans. In The Endocrine Pancreas. Edited by Samols E New York: Raven Press; 1991:337-354.
156. Olson LK, Redman JB, Towle HC, et al.: Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcripts and alters binding of insulin gene regulatory proteins. J Clin Invest 1993, 92:514-519.
157. Weaber G, Thompson N, Nicod P, et al.: Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor. Mol Endocrinol 1996, 10:1327-1334.
158. Zangen DH, Bonner-Weir S, Lee CH, et al.: Reduced insulin, GLUT2, and IDX-1 in B cells after partial pancreatectomy. Diabetes 1997, 46:258-264.
159. Watada H, Kayimoto Y, Kaneto H, et al.: Involvement of the homeodomain-containing transcription factor PDX-1 in islet amyloid polypeptide gene transcription. Biochem Biophys Res Commun 1996, 229:746-751.
160. Finegood D, McArthur M, Kojwang D, et al.: B-cell mass dynamics in Zucker diabetic fatty rats: rosiglitazone prevents the rise in net cell death. Diabetes 2001, 50:1021-1029.
161. Tuttle R, Gill N, Pugh W, et al.: Regulation of pancreatic B-cell growth and survival by the serine/threonine protein kinase Akt1/PKBa. Nat Med 2001, 7:1133-1137.
162. Bernal-Mizrachi E, Wen W, Stahlhut S, et al.: Islet B cell expression of constitutively active Akt1/PKBa induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Invest 2001, 108:1631-1638.